BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 21242973)

  • 1. Genome-wide screen reveals WNT11, a non-canonical WNT gene, as a direct target of ETS transcription factor ERG.
    Mochmann LH; Bock J; Ortiz-Tánchez J; Schlee C; Bohne A; Neumann K; Hofmann WK; Thiel E; Baldus CD
    Oncogene; 2011 Apr; 30(17):2044-56. PubMed ID: 21242973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ERG transcriptional networks in primary acute leukemia cells implicate a role for ERG in deregulated kinase signaling.
    Bock J; Mochmann LH; Schlee C; Farhadi-Sartangi N; Göllner S; Müller-Tidow C; Baldus CD
    PLoS One; 2013; 8(1):e52872. PubMed ID: 23300998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The oncofusion protein FUS-ERG targets key hematopoietic regulators and modulates the all-trans retinoic acid signaling pathway in t(16;21) acute myeloid leukemia.
    Sotoca AM; Prange KH; Reijnders B; Mandoli A; Nguyen LN; Stunnenberg HG; Martens JH
    Oncogene; 2016 Apr; 35(15):1965-76. PubMed ID: 26148230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GSK-3β inhibition promotes engraftment of ex vivo-expanded hematopoietic stem cells and modulates gene expression.
    Ko KH; Holmes T; Palladinetti P; Song E; Nordon R; O'Brien TA; Dolnikov A
    Stem Cells; 2011 Jan; 29(1):108-18. PubMed ID: 20960517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The combination of gene perturbation assay and ChIP-chip reveals functional direct target genes for IRF8 in THP-1 cells.
    Kubosaki A; Lindgren G; Tagami M; Simon C; Tomaru Y; Miura H; Suzuki T; Arner E; Forrest AR; Irvine KM; Schroder K; Hasegawa Y; Kanamori-Katayama M; Rehli M; Hume DA; Kawai J; Suzuki M; Suzuki H; Hayashizaki Y
    Mol Immunol; 2010 Aug; 47(14):2295-302. PubMed ID: 20573402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ERG promotes T-acute lymphoblastic leukemia and is transcriptionally regulated in leukemic cells by a stem cell enhancer.
    Thoms JA; Birger Y; Foster S; Knezevic K; Kirschenbaum Y; Chandrakanthan V; Jonquieres G; Spensberger D; Wong JW; Oram SH; Kinston SJ; Groner Y; Lock R; MacKenzie KL; Göttgens B; Izraeli S; Pimanda JE
    Blood; 2011 Jun; 117(26):7079-89. PubMed ID: 21536859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ERG induces a mesenchymal-like state associated with chemoresistance in leukemia cells.
    Mochmann LH; Neumann M; von der Heide EK; Nowak V; Kühl AA; Ortiz-Tanchez J; Bock J; Hofmann WK; Baldus CD
    Oncotarget; 2014 Jan; 5(2):351-62. PubMed ID: 24504051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrative genomic analyses of WNT11: transcriptional mechanisms based on canonical WNT signals and GATA transcription factors signaling.
    Katoh M; Katoh M
    Int J Mol Med; 2009 Aug; 24(2):247-51. PubMed ID: 19578797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FZD4 as a mediator of ERG oncogene-induced WNT signaling and epithelial-to-mesenchymal transition in human prostate cancer cells.
    Gupta S; Iljin K; Sara H; Mpindi JP; Mirtti T; Vainio P; Rantala J; Alanen K; Nees M; Kallioniemi O
    Cancer Res; 2010 Sep; 70(17):6735-45. PubMed ID: 20713528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GSK-3β inhibition preserves naive T cell phenotype in bone marrow reconstituted mice.
    Shen S; Klamer G; Xu N; O'Brien TA; Dolnikov A
    Exp Hematol; 2013 Dec; 41(12):1016-27.e1. PubMed ID: 24018603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lithium activates the Wnt and phosphatidylinositol 3-kinase Akt signaling pathways to promote cell survival in the absence of soluble survival factors.
    Sinha D; Wang Z; Ruchalski KL; Levine JS; Krishnan S; Lieberthal W; Schwartz JH; Borkan SC
    Am J Physiol Renal Physiol; 2005 Apr; 288(4):F703-13. PubMed ID: 15572521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low ERG and BAALC expression identifies a new subgroup of adult acute T-lymphoblastic leukemia with a highly favorable outcome.
    Baldus CD; Martus P; Burmeister T; Schwartz S; Gökbuget N; Bloomfield CD; Hoelzer D; Thiel E; Hofmann WK
    J Clin Oncol; 2007 Aug; 25(24):3739-45. PubMed ID: 17646667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycogen synthase kinase--3β inhibitors suppress leukemia cell growth.
    Song EY; Palladinetti P; Klamer G; Ko KH; Lindeman R; O'Brien TA; Dolnikov A
    Exp Hematol; 2010 Oct; 38(10):908-921.e1. PubMed ID: 20540984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of the MIR155 host gene in physiological and pathological processes.
    Elton TS; Selemon H; Elton SM; Parinandi NL
    Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of microRNA-196a and microRNA-196b as ERG regulators in acute myeloid leukemia and acute T-lymphoblastic leukemia.
    Coskun E; von der Heide EK; Schlee C; Kühnl A; Gökbuget N; Hoelzer D; Hofmann WK; Thiel E; Baldus CD
    Leuk Res; 2011 Feb; 35(2):208-13. PubMed ID: 20570349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of CXCL12 expression by canonical Wnt signaling in bone marrow stromal cells.
    Tamura M; Sato MM; Nashimoto M
    Int J Biochem Cell Biol; 2011 May; 43(5):760-7. PubMed ID: 21296678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. beta-catenin is involved in N-cadherin-dependent adhesion, but not in canonical Wnt signaling in E2A-PBX1-positive B acute lymphoblastic leukemia cells.
    Nygren MK; Døsen-Dahl G; Stubberud H; Wälchli S; Munthe E; Rian E
    Exp Hematol; 2009 Feb; 37(2):225-33. PubMed ID: 19101069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lycopene synergistically enhances quinacrine action to inhibit Wnt-TCF signaling in breast cancer cells through APC.
    Preet R; Mohapatra P; Das D; Satapathy SR; Choudhuri T; Wyatt MD; Kundu CN
    Carcinogenesis; 2013 Feb; 34(2):277-86. PubMed ID: 23129580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of the ETS-related gene, ERG, predicts a worse outcome in acute myeloid leukemia with normal karyotype: a Cancer and Leukemia Group B study.
    Marcucci G; Baldus CD; Ruppert AS; Radmacher MD; Mrózek K; Whitman SP; Kolitz JE; Edwards CG; Vardiman JW; Powell BL; Baer MR; Moore JO; Perrotti D; Caligiuri MA; Carroll AJ; Larson RA; de la Chapelle A; Bloomfield CD
    J Clin Oncol; 2005 Dec; 23(36):9234-42. PubMed ID: 16275934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sox17 and Sox4 differentially regulate beta-catenin/T-cell factor activity and proliferation of colon carcinoma cells.
    Sinner D; Kordich JJ; Spence JR; Opoka R; Rankin S; Lin SC; Jonatan D; Zorn AM; Wells JM
    Mol Cell Biol; 2007 Nov; 27(22):7802-15. PubMed ID: 17875931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.